Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
714 (USA) · Dr. Clarke
consented 2014-04-17
Adverse events
Moderate BRONCHITIS — outcome: RECOVERED/RESOLVED; onset 2014-07-18 (study day 93.0); relationship: NONE
Mild BUNDLE BRANCH BLOCK RIGHT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE
Mild BUNDLE BRANCH BLOCK RIGHT — outcome: RECOVERED/RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE
Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE
Mild ELECTROCARDIOGRAM T WAVE INVERSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-26 (study day 40.0); relationship: REMOTE
Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE
Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: RECOVERED/RESOLVED; onset 2014-06-04 (study day 49.0); relationship: REMOTE
Data queries
No data queries.